Correlation Between Centessa Pharmaceuticals and Stagwell

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Centessa Pharmaceuticals and Stagwell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Centessa Pharmaceuticals and Stagwell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Centessa Pharmaceuticals PLC and Stagwell, you can compare the effects of market volatilities on Centessa Pharmaceuticals and Stagwell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Centessa Pharmaceuticals with a short position of Stagwell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Centessa Pharmaceuticals and Stagwell.

Diversification Opportunities for Centessa Pharmaceuticals and Stagwell

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Centessa and Stagwell is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Centessa Pharmaceuticals PLC and Stagwell in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Stagwell and Centessa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Centessa Pharmaceuticals PLC are associated (or correlated) with Stagwell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Stagwell has no effect on the direction of Centessa Pharmaceuticals i.e., Centessa Pharmaceuticals and Stagwell go up and down completely randomly.

Pair Corralation between Centessa Pharmaceuticals and Stagwell

Given the investment horizon of 90 days Centessa Pharmaceuticals PLC is expected to generate 1.65 times more return on investment than Stagwell. However, Centessa Pharmaceuticals is 1.65 times more volatile than Stagwell. It trades about 0.13 of its potential returns per unit of risk. Stagwell is currently generating about 0.09 per unit of risk. If you would invest  1,350  in Centessa Pharmaceuticals PLC on September 2, 2024 and sell it today you would earn a total of  441.00  from holding Centessa Pharmaceuticals PLC or generate 32.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Centessa Pharmaceuticals PLC  vs.  Stagwell

 Performance 
       Timeline  
Centessa Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Centessa Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.
Stagwell 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Stagwell are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating technical and fundamental indicators, Stagwell showed solid returns over the last few months and may actually be approaching a breakup point.

Centessa Pharmaceuticals and Stagwell Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Centessa Pharmaceuticals and Stagwell

The main advantage of trading using opposite Centessa Pharmaceuticals and Stagwell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Centessa Pharmaceuticals position performs unexpectedly, Stagwell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Stagwell will offset losses from the drop in Stagwell's long position.
The idea behind Centessa Pharmaceuticals PLC and Stagwell pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
CEOs Directory
Screen CEOs from public companies around the world
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities